Toyo Gosei Co.,Ltd. (4970.T)
Tokyo, JP
Headquartered in Tokyo, Japan, Toyo Gosei Co., Ltd. has operated in the chemical sector since its establishment in 1954, initially as Nihon Acetylene Chemical Engineering Co., Ltd. before adopting its current name in 1961. The company primarily specializes in manufacturing and distributing photosensitive materials crucial for photolithography processes, particularly those involved in the precise microfabrication of semiconductor integrated circuits, liquid crystal displays, and color filters. Supporting these advanced applications, they also supply high-purity photo acid generators and resins essential for chemical amplification. Beyond its core offerings, Toyo Gosei diversifies its operations across multiple areas. It champions environmental efforts by recovering waste solvents and volatile organic compounds at its dedicated distillation facilities. The company also engages in the marketing of various synthetic products and provides specialized electrolytes and ionic liquids used in electric double-layer capacitors. Furthermore, Toyo Gosei produces aroma chemicals for a wide array of daily-use products, such as shampoos and body soaps, alongside flavorings for the food industry. Their research and development extends to creating materials for both batteries and electrical double-layer capacitors. Additionally, the company offers comprehensive logistics solutions, including warehousing, transportation services, and advanced systems for receiving, shipping, and analysis. Unique photosensitive materials for cell and protein enzyme culturing also form part of their product portfolio.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.11% | +5.18% | +54.81% | +70.61% | +166.87% | +141.95% | +256.18% | +136.20% | +58.37% | +2,303.23% | +780.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+8.5% ★ Q1'26: +20.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-17.9% Q1'26: +12.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+4.3% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+8.8% ★ Q1'26: +13.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%+8.3% ★ Q1'26: +16.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.65× Q1'26: 1.52× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2014 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 7 Rev. Ana. 7 EPS Ana. |
Mar 2027 5 Rev. Ana. 7 EPS Ana. |
Mar 2028 6 Rev. Ana. 6 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
14.94B
est: 14.94B (+0.0%)
|
20.54B
est: 20.10B (+2.2%)
|
22.98B
est: 22.50B (+2.1%)
|
24.46B
est: 24.15B (+1.3%)
|
27.16B
est: 26.43B (+2.8%)
|
33.14B
est: 32.24B (+2.8%)
|
34.16B
est: 34.38B (-0.7%)
|
31.96B
est: 31.28B (+2.2%)
|
38.67B
est: 38.84B (-0.5%)
|
41.53B
40.66B – 41.96B
+6.9% YoY
|
47.66B
45.60B – 49.91B
+14.8% YoY
|
52.60B
47.55B – 56.82B
+10.4% YoY
|
55.77B
55.63B – 55.91B
+6.0% YoY
|
| EBITDA |
1.37B
est: 3.12B (-56.1%)
|
3.03B
est: 4.19B (-27.8%)
|
3.57B
est: 4.69B (-23.9%)
|
4.31B
est: 5.04B (-14.5%)
|
5.28B
est: 5.51B (-4.2%)
|
7.32B
est: 6.72B (+8.9%)
|
7.83B
est: 7.17B (+9.2%)
|
6.29B
est: 6.52B (-3.6%)
|
7.79B
est: 7.27B (+7.2%)
|
7.77B
7.61B – 7.85B
+6.9% YoY
|
8.92B
8.54B – 9.34B
+14.8% YoY
|
9.85B
8.90B – 10.64B
+10.4% YoY
|
10.44B
10.41B – 10.47B
+6.0% YoY
|
| EBIT |
-422.40M
est: 1.86B (-122.7%)
|
1.34B
est: 2.50B (-46.5%)
|
1.63B
est: 2.80B (-41.9%)
|
2.13B
est: 3.01B (-29.1%)
|
3.07B
est: 3.29B (-6.6%)
|
4.86B
est: 4.01B (+21.0%)
|
5.16B
est: 4.28B (+20.6%)
|
3.39B
est: 3.89B (-12.9%)
|
4.08B
est: 4.64B (-12.0%)
|
4.96B
4.85B – 5.01B
+6.9% YoY
|
5.69B
5.44B – 5.96B
+14.8% YoY
|
6.28B
5.68B – 6.78B
+10.4% YoY
|
6.66B
6.64B – 6.67B
+6.0% YoY
|
| Net Income |
-673.15M
est: -673.00M (0.0%)
|
863.06M
est: 800.03M (+7.9%)
|
1.17B
est: 869.88M (+34.6%)
|
1.85B
est: 1.65B (+12.3%)
|
2.35B
est: 1.80B (+30.3%)
|
3.46B
est: 3.06B (+13.2%)
|
3.83B
est: 3.60B (+6.2%)
|
2.40B
est: 1.92B (+24.8%)
|
3.28B
est: 2.74B (+19.5%)
|
2.25B
2.02B – 2.44B
-18.1% YoY
|
4.07B
3.69B – 4.81B
+81.0% YoY
|
5.58B
4.50B – 7.70B
+37.2% YoY
|
6.91B
4.58B – 9.18B
+23.8% YoY
|
| SGA |
2.51B
est: 1.39B (+81.5%)
|
1.91B
est: 1.86B (+2.4%)
|
2.09B
est: 2.09B (+0.3%)
|
2.17B
est: 2.24B (-2.9%)
|
2.30B
est: 2.45B (-5.9%)
|
2.65B
est: 2.99B (-11.3%)
|
2.91B
est: 3.19B (-8.8%)
|
2.73B
est: 2.90B (-5.9%)
|
4.96B
est: 3.94B (+25.9%)
|
4.21B
4.12B – 4.25B
+6.9% YoY
|
4.83B
4.62B – 5.06B
+14.8% YoY
|
5.33B
4.82B – 5.76B
+10.4% YoY
|
5.65B
5.64B – 5.67B
+6.0% YoY
|
| EPS |
-84.81
est: -84.79 (0.0%)
|
108.73
est: 100.80 (+7.9%)
|
147.54
est: 109.60 (+34.6%)
|
233.43
est: 207.90 (+12.3%)
|
295.57
est: 230.13 (+28.4%)
|
435.61
est: 389.16 (+11.9%)
|
482.21
est: 434.25 (+11.0%)
|
301.88
est: 247.18 (+22.1%)
|
413.14
est: 342.00 (+20.8%)
|
282.94
254.84 – 307.20
-17.3% YoY
|
508.83
464.75 – 605.91
+79.8% YoY
|
702.77
566.70 – 970.15
+38.1% YoY
|
866.69
577.14 – 1,156.25
+23.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 191.2K | 0.40% |
| 2 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 1.10M | 0.06% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 2.08M | 0.06% |
| 4 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 10.8K | 0.22% |
| 5 | Vanguard FTSE Pacific ETF VPL | 0.00% | 630.9K | 0.07% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 9.6K | 0.30% |
| 7 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | 341.2K | 0.18% |
| 8 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 12.9K | 0.22% |
| 9 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 149.0K | 0.23% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 123.7K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yujin Kimura | President & Representative Director | 294M | male |
| Akira Deki | GM of Chemicals Division, Executive MD & Director | — | male |
| Hideki Shibuya | Executive Officer & GM of Human Resources Department | — | — |
| Natsuo Watase | GM of Corporation Planning Department & Director | — | male |
| Satomi Hirasawa | GM of Photosensitive Materials Division & Director | — | — |
| Shiro Shinozaki | Executive officer and GM of Financial & Accounting Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4970.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
